OEM manufacturer Olive Nuts Extract - Genistein – Chenlv
OEM manufacturer Olive Nuts Extract - Genistein – Chenlv Detail:
Appearance: white fine powder
Test method: HPLC
Molecular Formula: C15H10O5
An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.
Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in Felmingia vestita, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode.
Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women 1.
Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin.
Product packing: 25kg/drum
Validity period: 2 years
Product detail pictures:
Related Product Guide:
The really abundant projects management experiences and 1 to just one provider model make the high importance of business enterprise communication and our easy understanding of your expectations for OEM manufacturer Olive Nuts Extract - Genistein – Chenlv, The product will supply to all over the world, such as: The Swiss , Yemen , Sao Paulo , We pay high attention to customer service, and cherish every customer. We've maintained a strong reputation in the industry for many years. We are honest and work on building a long-term relationship with our customers.
By Annabelle from Poland - 2018.06.12 16:22
Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
By Joa from Swaziland - 2017.12.31 14:53